Similar Articles

Supportive Group Therapy in Multiple Sclerosis

Şule Özden TOPKAYA, Meral OĞUZ, Fatma UZUNEL, Serkan ÖZAKBAŞ, Köksal ALPTEKİN, Egemen İDİMAN

Issue: 2003, Volume 9 - Issue 1
0 200

Flash-Electroretinographic Investigation of Retina Dysfunction in Subjects With Multiple Sclerosis

Temel TOMBUL, Ömer ANLAR, Adnan ÇINAL, Osman TANIK

Issue: 2002, Volume 8 - Issue 4
0 229

Necessity of Psychological Support in Patients with Multiple Sclerosis

Şule Özden TOPKAYA, Meral OĞUZ, Fatma UZUNYEL, Serkan ÖZAKBAŞ, Köksal ALPTEKİN, Egemen İDİMAN

Issue: 2002, Volume 8 - Issue 4
0 200

Causes of Death in Multiple Sclerosis: Cross-sectional Analysis of 16 Years Period

Serkan ÖZAKBAŞ, Burak PAKÖZ, İhsan Şükrü ŞENGÜN, Barış BAKLAN, Göksemin DEMİR, Bülent ÜNLÜ, Zuhal BAHAR, Egemen İDİMAN

Issue: 2002, Volume 8 - Issue 2
0 221

Experiences of lnterferon Beta-1b Treatment After 5-Year Follow-U

Serkan ÖZAKBAŞ, Egemen İDİMAN, Burak PAKÖZ, Berril DÖNMEZ, Utku UYSAL

Issue: 2002, Volume 8 - Issue 1
0 203

A Case of Mu/tiple Sclerosis Presenting As Unilateral Papillitis

Nurgül YILMAZ, Ebru ÖZAY, Funda AÇIKGÖZ, Nursel AYDIN

Issue: 2002, Volume 8 - Issue 1
0 256

Multimodal Evoked Potentialsin Follow-up of Treatment of Multiple Sclerosis With lnterferon Beta-1 a

Serkan ÖZAKBAŞ, Raif ÇAKMUR, Vesile ÖZTÜRK, Egemen İDİMAN, Fethi İDİMAN

Issue: 2001, Volume 7 - Issue 1
0 183

lnterferon Beta-1b In TheTreatment Of Relapsing Remitting Multiple Sclerosis:Clinical and Magnetic Resonance lmaging Results

Serkan ÖZAKBAŞ, Egemen İDİMAN, Handan ÇAKMAKÇI, İlhami KOVANLIKAYA

Issue: 2001, Volume 7 - Issue 1
0 217

Cytokines in Multiple Sclerosis

A. ALTINTAŞ, O. KANTARCI, S. SAİP, A. SİVA, S. ÖZTUZCU, N. HEKİM, P. BOZKURT

Issue: 2000, Volume 6 - Issue 4
0 178

Beta lnterferon-lA Treatment in Multipl Sclerosis and Cognitive Functions

E. İDİMAN, G. G. YENER, G. AKDAL, S. ÖZAKBAŞ

Issue: 2000, Volume 6 - Issue 4
0 185

The Effect of Methylprednisolone on Disease Progression in Relapsing Remitting Multiple Sclerosis: six year-follow up results.

D. İ. GÜNAL, M. GÜLERYÜZ, E. KARAGÖZ, N. BEKİROĞLU, S. AKTAN

Issue: 1999, Volume 5 - Issue 1
0 163

Multiple Sclerosis and Fatigue

Nur YÜCEYAR, Ayşe SAĞDUYU

Issue: 1999, Volume 5 - Issue 1
0 154

Basic Concept in Neuroimmunology

Egemen İDİMAN

Issue: 1997, Volume 3 - Issue 3-4
0 152

Clinical Scales for Multiple Sclerosis

Kadriye ARMUTLU, Rana KARABUDAK

Issue: 1997, Volume 3 - Issue 3-4
0 229

HLA Tissue Antigens in Multiple Sclerosis

Yaşar ZORLU, Fadime GÜVEN, Serdar KESKEN, Füsun KARAASLAN, Halis GÜGÜL

Issue: 1996, Volume 2 - Issue 3-4
0 167

Serum Vitamin B12 and Folate Levels in Multiple Sclerosis

H. Özden ŞENER, Serpil DEMİRCİ, Nermin MUTLUER

Issue: 1996, Volume 2 - Issue 3-4
0 226

Effect of lntravenous Methylprednisolone (IVMP) on Clinical and Neurophysiological Parameters in Multiple Sclerosis.

Yaşar KÜTÜKÇÜ, Zeki GÖKÇİL, Zeki ODABAŞI, Okay VURAL, Muzaffer YARDIM

Issue: 1996, Volume 2 - Issue 1-2
0 157

THE ROLE OF CYTOKINES IN MULTIPLE SCLEROSIS

Ayşe ALTINTAŞ, Orhun KANTARCI, Aksel SİVA

Issue: 1995, Volume 1 - Issue 4
0 160

Multiple Sclerosis Cases with Atypical Signs

Türe TUNÇBAY, Dilek EVYAPAN, Neşe ÇELEBİSOY

Issue: 1995, Volume 1 - Issue 2
0 171

Evaluation of Depression and Anxiety of Patients with Multiple Sclerosis During the COVID-19 Pandemic: A Comparison with the General Population

Gizem Yağmur Yalçın, Cansu Polat Dunya, Zeliha Tülek, Murat Kürtüncü, Mefkure Eraksoy

DOI: 10.4274/tnd.2021.63444

Issue: 2021, Volume 27 - Supplement 1
0 290